KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Other Operating Expenses: 2010-2025

Historic Other Operating Expenses for Exact Sciences (EXAS) over the last 16 years, with Sep 2025 value amounting to $250.8 million.

  • Exact Sciences' Other Operating Expenses rose 7989.39% to $250.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $771.0 million, marking a year-over-year increase of 5816.34%. This contributed to the annual value of $9.2 million for FY2024, which is 88.27% down from last year.
  • As of Q3 2025, Exact Sciences' Other Operating Expenses stood at $250.8 million, which was up 1.48% from $247.1 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Other Operating Expenses registered a high of $393.5 million during Q2 2022, and its lowest value of -$204.5 million during Q4 2022.
  • Its 3-year average for Other Operating Expenses is $147.7 million, with a median of $72.0 million in 2023.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 171.22% in 2022, then surged by 101,055.60% in 2025.
  • Exact Sciences' Other Operating Expenses (Quarterly) stood at $287.1 million in 2021, then crashed by 171.22% to -$204.5 million in 2022, then soared by 103.13% to $6.4 million in 2023, then tumbled by 59.88% to $2.6 million in 2024, then surged by 7,989.39% to $250.8 million in 2025.
  • Its last three reported values are $250.8 million in Q3 2025, $247.1 million for Q2 2025, and $270.6 million during Q1 2025.